相关实验视频

Updated: Jun 18, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

一种超越AMA1-RON2L疟疾疫苗菌株的结构设计

Palak N Patel¹, Thayne H Dickey¹, Ababacar Diouf²

¹Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Nature communications

|September 2, 2023

概括

一种新型疟疾疫苗候选者SBD1产生强大的抗体,对抗Plasmodium falciparum. 这种单组件免疫原为下一代疟疾和虫复杂寄生虫控制提供了一个有前途的战略.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
寄生虫学的寄生虫学

背景情况:

甲状腺膜抗原1 (AMA1) 是疟疾疫苗的关键目标.
亚马1-RON2L复合体对于亚马复合体寄生虫入侵至关重要,也是免疫的目标.
之前的研究表明,AMA1-RON2L复合免疫增强了与单独的AMA1相比的保护.

研究的目的:

设计和评估模仿AMA1-RON2L复杂结构的单组件免疫原体.
评估这些新型免疫原的免疫性和有效性.
研究这些免疫原因诱导的中和机制.

主要方法:

三个单组件AMA1-RON2L免疫原体 (SBD1和两个插入融合) 的设计.
用设计的免疫原和对照剂 (AMA1,AMA1-RON2L复合物) 免疫小鼠.
评估抗体标位,增长抑制活性,以及对各种Plasmodium falciparum菌株的中和抗体反应.

主要成果:

所有设计的免疫原都诱导了高抗体标位和增长抑制活性.
生成的抗体没有阻止RON2L与AMA1结合.
这种SBD1免疫原产生了比AMA1或AMA1-RON2L复合疫苗更有效的超越菌株的中和抗体.
这些中和反应针对独立于RON2L结合的AMA1表位素.

结论:

单组件免疫原,特别是SBD1,可以引起强大的超越菌株的中和抗体反应.
与RON2L结合封锁不同的中和机制对疟疾寄生虫有效.
SBD1代表了开发下一代针对疟疾和其他虫寄生虫的疫苗的有希望的候选人.

更多相关视频

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

相关概念视频

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...